BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38063815)

  • 1. Impact of Chemotherapeutic Stress Depends on The Nature of Breast Cancer Spheroid and Induce Behavioral Plasticity to Resistant Population.
    Gayan S; Teli A; Sonawane A; Dey T
    Adv Biol (Weinh); 2024 Apr; 8(4):e2300271. PubMed ID: 38063815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testing chemotherapy efficacy in HER2 negative breast cancer using patient-derived spheroids.
    Halfter K; Hoffmann O; Ditsch N; Ahne M; Arnold F; Paepke S; Grab D; Bauerfeind I; Mayer B
    J Transl Med; 2016 May; 14(1):112. PubMed ID: 27142386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automated Assessment of Cancer Drug Efficacy On Breast Tumor Spheroids in Aggrewell™400 Plates Using Image Cytometry.
    Mukundan S; Bell J; Teryek M; Hernandez C; Love AC; Parekkadan B; Chan LL
    J Fluoresc; 2022 Mar; 32(2):521-531. PubMed ID: 34989923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Citral induced apoptosis in MDA-MB-231 spheroid cells.
    Nigjeh SE; Yeap SK; Nordin N; Kamalideghan B; Ky H; Rosli R
    BMC Complement Altern Med; 2018 Feb; 18(1):56. PubMed ID: 29433490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of size and shape of the ovarian cancer spheroids on the drug resistance and migration.
    Gunay G; Kirit HA; Kamatar A; Baghdasaryan O; Hamsici S; Acar H
    Gynecol Oncol; 2020 Nov; 159(2):563-572. PubMed ID: 32958270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of α-Mangostin on Viability, Growth and Cohesion of Multicellular Spheroids Derived from Human Breast Cancer Cell Lines.
    Scolamiero G; Pazzini C; Bonafè F; Guarnieri C; Muscari C
    Int J Med Sci; 2018; 15(1):23-30. PubMed ID: 29333084
    [No Abstract]   [Full Text] [Related]  

  • 7. A polymer microstructure array for the formation, culturing, and high throughput drug screening of breast cancer spheroids.
    Markovitz-Bishitz Y; Tauber Y; Afrimzon E; Zurgil N; Sobolev M; Shafran Y; Deutsch A; Howitz S; Deutsch M
    Biomaterials; 2010 Nov; 31(32):8436-44. PubMed ID: 20692698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing Advantages and Drawbacks of Rapidly Generated Ultra-Large 3D Breast Cancer Spheroids: Studies with Chemotherapeutics and Nanoparticles.
    Holub AR; Huo A; Patel K; Thakore V; Chhibber P; Erogbogbo F
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glioblastoma spheroid growth and chemotherapeutic responses in single and dual-stiffness hydrogels.
    Bruns J; Egan T; Mercier P; Zustiak SP
    Acta Biomater; 2023 Jun; 163():400-414. PubMed ID: 35659918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective cohort study using the breast cancer spheroid model as a predictor for response to neoadjuvant therapy--the SpheroNEO study.
    Halfter K; Ditsch N; Kolberg HC; Fischer H; Hauzenberger T; von Koch FE; Bauerfeind I; von Minckwitz G; Funke I; Crispin A; Mayer B;
    BMC Cancer; 2015 Jul; 15():519. PubMed ID: 26169261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A more aggressive breast cancer spheroid model coupled to an electronic capillary sensor system for a high-content screening of cytotoxic agents in cancer therapy: 3-dimensional in vitro tumor spheroids as a screening model.
    Bartholomä P; Impidjati ; Reininger-Mack A; Zhang Z; Thielecke H; Robitzki A
    J Biomol Screen; 2005 Oct; 10(7):705-14. PubMed ID: 16131482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of intercellular communications in breast cancer multicellular tumor spheroids after chemotherapy.
    Oktem G; Bilir A; Ayla S; Yavasoglu A; Goksel G; Saydam G; Uysal A
    Oncol Res; 2006; 16(5):225-33. PubMed ID: 17294803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diversity of cell-mediated adhesions in breast cancer spheroids.
    Ivascu A; Kubbies M
    Int J Oncol; 2007 Dec; 31(6):1403-13. PubMed ID: 17982667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of P-glycoprotein function by XR9576 in a solid tumour model can restore anticancer drug efficacy.
    Walker J; Martin C; Callaghan R
    Eur J Cancer; 2004 Mar; 40(4):594-605. PubMed ID: 14962729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mimicking the tumor microenvironment to regulate macrophage phenotype and assessing chemotherapeutic efficacy in embedded cancer cell/macrophage spheroid models.
    Tevis KM; Cecchi RJ; Colson YL; Grinstaff MW
    Acta Biomater; 2017 Mar; 50():271-279. PubMed ID: 28011141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-time viability and apoptosis kinetic detection method of 3D multicellular tumor spheroids using the Celigo Image Cytometer.
    Kessel S; Cribbes S; Bonasu S; Rice W; Qiu J; Chan LL
    Cytometry A; 2017 Sep; 91(9):883-892. PubMed ID: 28618188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spheroid-forming subpopulation of breast cancer cells demonstrates vasculogenic mimicry via hsa-miR-299-5p regulated de novo expression of osteopontin.
    Shevde LA; Metge BJ; Mitra A; Xi Y; Ju J; King JA; Samant RS
    J Cell Mol Med; 2010 Jun; 14(6B):1693-706. PubMed ID: 19538464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D high-content screening for the identification of compounds that target cells in dormant tumor spheroid regions.
    Wenzel C; Riefke B; Gründemann S; Krebs A; Christian S; Prinz F; Osterland M; Golfier S; Räse S; Ansari N; Esner M; Bickle M; Pampaloni F; Mattheyer C; Stelzer EH; Parczyk K; Prechtl S; Steigemann P
    Exp Cell Res; 2014 Apr; 323(1):131-143. PubMed ID: 24480576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3D bioprinted drug-resistant breast cancer spheroids for quantitative in situ evaluation of drug resistance.
    Hong S; Song JM
    Acta Biomater; 2022 Jan; 138():228-239. PubMed ID: 34718182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Triple Combination of Metformin, Acetylsalicylic Acid, and Oseltamivir Phosphate Impacts Tumour Spheroid Viability and Upends Chemoresistance in Triple-Negative Breast Cancer.
    Sambi M; Samuel V; Qorri B; Haq S; Burov SV; Markvicheva E; Harless W; Szewczuk MR
    Drug Des Devel Ther; 2020; 14():1995-2019. PubMed ID: 32546966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.